• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Myeloablative BU, fludarabine, antithymocyte globulin and low-dose TBI in the treatment of juvenile myelomonocytic leukaemia with allogeneic haematopoietic cell transplantation.

作者信息

Guilcher G M T, Moorjani R, Truong T H, Lewis V A

机构信息

University of Calgary, Section of Haematology/Oncology/Transplant, Alberta Children's Hospital, Calgary, Canada.

出版信息

Bone Marrow Transplant. 2015 Mar;50(3):455-6. doi: 10.1038/bmt.2014.272. Epub 2014 Dec 8.

DOI:10.1038/bmt.2014.272
PMID:25486583
Abstract
摘要

相似文献

1
Myeloablative BU, fludarabine, antithymocyte globulin and low-dose TBI in the treatment of juvenile myelomonocytic leukaemia with allogeneic haematopoietic cell transplantation.
Bone Marrow Transplant. 2015 Mar;50(3):455-6. doi: 10.1038/bmt.2014.272. Epub 2014 Dec 8.
2
Reduced-intensity conditioning using fludarabine with either antithymocyte globulin and BU, or low-dose TBI allowing allogeneic hematopoietic SCT.采用氟达拉滨联合抗胸腺细胞球蛋白和 BU 或低剂量 TBI 进行减强度预处理，以进行异基因造血干细胞移植。
Bone Marrow Transplant. 2010 Jan;45(1):31-7. doi: 10.1038/bmt.2009.126. Epub 2009 Jun 22.
3
Clinical Relevance of Apheretic Graft Composition in Patients With Acute Myeloblastic Leukemia Who Received a Busulfan-Fludarabine-Antithymocyte Globulin Conditioning Regimen for Allogeneic Transplant.接受白消安-氟达拉滨-抗胸腺细胞球蛋白预处理方案进行异基因移植的急性髓细胞白血病患者中，去除性移植物组成的临床相关性
Exp Clin Transplant. 2015 Oct;13(5):453-60. doi: 10.6002/ect.2014.0223. Epub 2015 Jun 15.
4
Fludarabine, antithymocyte globulin, and very low-dose busulfan for reduced-intensity conditioning before allogeneic stem cell transplantation in patients with lymphoid malignancies.氟达拉滨、抗胸腺细胞球蛋白和极低剂量白消安用于淋巴细胞恶性肿瘤患者异基因造血干细胞移植前的低强度预处理。
Biol Blood Marrow Transplant. 2011 Nov;17(11):1698-703. doi: 10.1016/j.bbmt.2011.04.010. Epub 2011 May 3.
5
Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study.ASCT1221 研究中儿童幼年骨髓单核细胞白血病的疾病负担和预处理方案：一项儿童肿瘤协作组的随机 II 期试验。
Pediatr Blood Cancer. 2018 Jul;65(7):e27034. doi: 10.1002/pbc.27034. Epub 2018 Mar 12.
6
A reduced intensity conditioning regimen of fludarabine, cyclophosphamide, antithymocyte globulin, plus 2 Gy TBI facilitates successful hematopoietic cell engraftment in an adult with dyskeratosis congenita.
Bone Marrow Transplant. 2012 Sep;47(9):1254-5. doi: 10.1038/bmt.2011.257. Epub 2012 Jan 16.
7
Non-myeloablative conditioning regimen of fludarabine, busulfan, anti-thymocyte globulin, and methylprednisolone for allogeneic peripheral blood hematopoietic cell transplantation.用于异基因外周血造血细胞移植的氟达拉滨、白消安、抗胸腺细胞球蛋白和甲泼尼龙非清髓性预处理方案。
Haematologica. 2001 Sep;86(9):999-1001.
8
Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation: a prospective randomized trial.氟达拉滨与克拉屈滨加白消安及低剂量全身照射作为异基因造血干细胞移植的减低强度预处理：一项前瞻性随机试验。
Bone Marrow Transplant. 2007 Feb;39(4):193-9. doi: 10.1038/sj.bmt.1705556. Epub 2007 Jan 15.
9
Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML.采用静脉注射白消安、氟达拉滨和兔抗胸腺细胞球蛋白对患有非恶性疾病和慢性粒细胞白血病的儿童进行减低强度预处理。
Bone Marrow Transplant. 2006 Feb;37(3):263-9. doi: 10.1038/sj.bmt.1705240.
10
Comparison of new flu-bu12-tg conditioning with the standard bu-cy myeloablative regimen in patients undergoing allogeneic stem cell transplantation for acute myeloid leukemia.新的氟达拉滨-白消安-环磷酰胺预处理方案与标准白消安-环磷酰胺清髓方案在接受异基因干细胞移植治疗急性髓系白血病患者中的比较。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Dec;155(4):327-32. doi: 10.5507/bp.2011.040.

引用本文的文献

1
Two Different Transplant Preconditioning Regimens Combined with Irradiation and Chemotherapy in the Treatment of Childhood Leukemia: Systematic Review and Meta-Analysis.两种不同的移植预处理方案联合放疗和化疗治疗儿童白血病：系统评价和荟萃分析。
J Healthc Eng. 2022 Mar 18;2022:2825712. doi: 10.1155/2022/2825712. eCollection 2022.

本文引用的文献

1
Juvenile myelomonocytic leukemia: molecular pathogenesis informs current approaches to therapy and hematopoietic cell transplantation.青少年髓单核细胞白血病：分子发病机制为当前的治疗方法和造血细胞移植提供了信息。
Front Pediatr. 2014 Mar 28;2:25. doi: 10.3389/fped.2014.00025. eCollection 2014.
2
Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia.近期在少年骨髓单核细胞白血病的发病机制和治疗方面的进展。
Br J Haematol. 2011 Mar;152(6):677-87. doi: 10.1111/j.1365-2141.2010.08525.x.
3
The addition of 400 cGY total body irradiation to a regimen incorporating once-daily intravenous busulfan, fludarabine, and antithymocyte globulin reduces relapse without affecting nonrelapse mortality in acute myelogenous leukemia.
在包含每日一次静脉注射白消安、氟达拉滨和抗胸腺细胞球蛋白的方案中加入 400 cGY 全身照射可降低复发率而不影响急性髓系白血病的非复发死亡率。
Biol Blood Marrow Transplant. 2010 Apr;16(4):509-14. doi: 10.1016/j.bbmt.2009.11.017. Epub 2009 Dec 3.
4
Reduced-toxicity conditioning therapy with allogeneic stem cell transplantation for acute leukemia.异基因干细胞移植治疗急性白血病的低毒性预处理疗法
Curr Opin Oncol. 2009 Jun;21 Suppl 1(Suppl 1):S11-5. doi: 10.1097/01.cco.0000357469.83960.12.
5
Juvenile myelomonocytic leukemia: a report from the 2nd International JMML Symposium.青少年骨髓单核细胞白血病：第二届国际青少年骨髓单核细胞白血病研讨会报告
Leuk Res. 2009 Mar;33(3):355-62. doi: 10.1016/j.leukres.2008.08.022. Epub 2008 Oct 26.
6
Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.作为急性髓系白血病/骨髓增生异常综合征（AML/MDS）移植前预处理疗法，每日一次静脉注射白消安和氟达拉滨（静脉注射Bu-Flu）与静脉注射白消安和环磷酰胺（静脉注射BuCy2）相比具有优势。
Biol Blood Marrow Transplant. 2008 Jun;14(6):672-84. doi: 10.1016/j.bbmt.2008.03.009.
7
A conditioning regimen of busulfan, fludarabine, and melphalan for allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia.白消安、氟达拉滨和美法仑预处理方案用于青少年型骨髓单核细胞白血病患儿的异基因干细胞移植
Pediatr Transplant. 2008 Dec;12(8):862-7. doi: 10.1111/j.1399-3046.2008.00931.x. Epub 2008 Apr 6.
8
Allogeneic transplantation for adult acute leukemia in first and second remission with a novel regimen incorporating daily intravenous busulfan, fludarabine, 400 CGY total-body irradiation, and thymoglobulin.采用包含每日静脉注射白消安、氟达拉滨、400 cGy全身照射及抗胸腺细胞球蛋白的新型方案，对处于首次和第二次缓解期的成人急性白血病进行异基因移植。
Biol Blood Marrow Transplant. 2007 Jul;13(7):814-21. doi: 10.1016/j.bbmt.2007.03.003. Epub 2007 Apr 23.
9
Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia.急性淋巴细胞白血病婴儿的异基因造血细胞移植
Blood. 2005 May 1;105(9):3749-56. doi: 10.1182/blood-2004-08-3312. Epub 2005 Jan 6.
10
Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial.青少年粒单核细胞白血病（JMML）患儿的造血干细胞移植（HSCT）：EWOG-MDS/EBMT试验结果
Blood. 2005 Jan 1;105(1):410-9. doi: 10.1182/blood-2004-05-1944. Epub 2004 Sep 7.